Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734303 · ClinicalTrials.gov registry record
Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 90
- Enrollment target
NCT02734303: Completed study, sponsored by National Cancer Institute (NCI).
NCT02734303 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02734303 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Background: The first nuclear bomb test took place in New Mexico in July 1945. This was called the Trinity test. Researchers want to learn how it affected the health of people who lived in New Mexico at the time of the test. To do this, they want to learn about the diet and daily life of those people at that time. They want to study Native Americans, Hispanic/Latinos, and non-Hispanic/Latino whites. Objective: To learn about the health risks for people who may have been exposed to radiation from the Trinity nuclear test. Eligibility: People who: * Are Native American, Hispanic/Latino, or non-Hispanic white * Are age 70 and older * Lived near the fallout region of the Trinity test and know about lifestyle and dietary patterns in New Mexico in the 1940s and 1950s Design: Participants will be screened with a questionnaire. Participants will answer questions in an interview or a focus group. This will be at a place like an office, tribal or community center, or library. It will take up to 2 hours. The interview or group session will include: * Questions about their and their family members activities and eating habits in the 1940s and 1950s * A card-sorting exercise: There will be cards with pictures and names of certain foods. They will sort the cards into 2 piles: those that were consumed and those that were not. * Filling out a chart of their family members and the foods they ate If participants give permission, their interview or group session will be recorded. ...
Primary Outcome
prediction of number of excess cancers of: colon, lung, active bone marrow, stomach, and thyroid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2016-03-17 |
| Est. Completion | 2019-12-01 |
What the finished NCT02734303 record still lists
NCT02734303 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02734303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02734303 about?
NCT02734303 is a clinical study titled "Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test". Background: The first nuclear bomb test took place in New Mexico in July 1945. This was called the Trinity test. Researchers want to learn how it affected the health of people who lived in New Mexico at the time of the test. To do this, they want to learn about the diet and daily life of those peop...
What is the current status of trial NCT02734303?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2016-03-17. Estimated completion is 2019-12-01.
Who is sponsoring clinical trial NCT02734303?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI